Fight Colorectal Cancer Rings NADSAQ Closing Bell

FOR IMMEDIATE RELEASE Fight Colorectal Cancer Rings NADSAQ Closing Bell To Kick off 2016 Colorectal Cancer Awareness Month Advocacy organization Fight Colorectal Cancer will be kicking off a March full of awareness activities in NYC’s Times Square. ALEXANDRIA, Va., Feb. 29, 2016 – Colorectal cancer…

Read Full Post

Fight Colorectal Cancer Heads to Minnesota for Pitch for Prevention

FOR IMMEDIATE RELEASE National March Against Colorectal Cancer Heads to Minnesota Twins’ Target Field for Pitch for Prevention Fight Colorectal Cancer’s coast-to-coast colorectal cancer awareness campaign, One Million Strong, is collaborating with Mayo Clinic and prostate cancer group Ed Randall’s Fans for the Cure to…

Read Full Post

Avastin Users Wanted for New Research Study

Fight Colorectal Cancer is partnering together with 23andme and Genentech to help researchers better understand if patients’ genes play a role in how they respond to treatments they receive for their colorectal cancer.  This provides patients a new opportunity to participate in genetics research. You…

Read Full Post

Fake Avastin Discovered in US

The Food and Drug Adminstration and Genentech have reported that counterfeit Avastin is being distributed in the United States. The counterfeit medicine does not contain bevacizumab, Avastin’s active ingredient. The packaging is different from genuine Avastin marketed here by Genentech. It includes a Roche logo…

Read Full Post

C-08 Avastin Trial Didn't Meet Primary Goal

When Avastin® (bevacizumab) was added to standard chemotherapy after surgery, it didn’t reduce the risk that early stage colon cancer would return, according to a press release this morning from Genentech. NSABP C-08 randomly assigned patients with stage II or III colon cancer to FOLFOX chemotherapy with or…

Read Full Post